z-logo
open-access-imgOpen Access
LOW DOSE SPIRONOLACTONE PROTECTS EXPERIMENTALLY-INDUCED POLYCYSTIC OVARIAN SYNDROME FROM INSULIN-RESISTANT METABOLIC DISTURBANCES
Author(s) -
Oluwaseun Adeyanju,
Timothy Falodun
Publication year - 2021
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/01.hjh.0000744648.83946.ef
Subject(s) - medicine , endocrinology , spironolactone , insulin resistance , hyperandrogenism , metabolic syndrome , testosterone (patch) , mineralocorticoid receptor , polycystic ovary , dyslipidemia , luteinizing hormone , metformin , infertility , diabetes mellitus , hormone , aldosterone , biology , pregnancy , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here